ENGOT-ov50/GOG-3029/INNOVATE-3

Trial Description: 
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 200kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer
Lead Cooperative Group: 
Disease Site: 
Recurrent Ovarian
Trial Status: 
Recruiting
Contact person: